三生国健(688336)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688336 三生国健

已收盘 07-22 15:00:00

{"stockData":{"symbol":"688336","market":"SH","secType":"STK","nameCN":"三生国健","latestPrice":19.66,"timestamp":1721631600000,"preClose":19.38,"halted":0,"volume":1529242,"delay":0,"floatShares":617000000,"shares":617000000,"eps":0.5711,"marketStatus":"已收盘","marketStatusCode":5,"change":0.28,"latestTime":"07-22 15:00:00","open":19.32,"high":19.96,"low":19.2,"amount":30047600,"amplitude":0.0392,"askPrice":19.7,"askSize":3,"bidPrice":19.66,"bidSize":137,"shortable":0,"etf":0,"ttmEps":0.5711,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"adjPreClose":19.38,"symbolType":"stock_kcb","openAndCloseTimeList":[[1721611800000,1721619000000],[1721624400000,1721631600000]],"highLimit":21.32,"lowLimit":17.44,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":616785793,"pbRate":2.43,"roa":"--","roe":"1.84%","epsLYR":0.48,"committee":0.620253,"marketValue":12126000000,"floatMarketCap":12126000000,"peRate":34.424794,"changeRate":0.0144,"turnoverRate":0.0025,"status":0,"afterMarket":{"amount":0,"volume":0,"close":19.66,"buyVolume":0,"sellVolume":0,"time":1721633637153,"indexStatus":"已收盘 07-22 15:30:00","preClose":19.38}},"requestUrl":"/m/hq/s/688336","defaultTab":"news","newsList":[{"id":"2453220126","title":"三生国健（688336）5.24亿股限售股将于7月22日解禁，占总股本84.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453220126","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453220126?lang=zh_cn&edition=full","pubTime":"2024-07-22 08:03","pubTimestamp":1721606601,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，三生国健于7月22日将有5.24亿股限售股份解禁，为公司追加承诺限售股份上市流通，占公司总股本84.96%。本次解禁后，公司已无限售股份。三生国健主营业务：从事抗体药物的研发、生产及销售业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200001679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688336"],"gpt_icon":0},{"id":"2452493494","title":"北向资金7月18日净卖出三生国健6.66万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2452493494","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452493494?lang=zh_cn&edition=full","pubTime":"2024-07-19 09:30","pubTimestamp":1721352641,"startTime":"0","endTime":"0","summary":"7月18日，北向资金减持三生国健6.66万股连续3日减持。截止当日收盘，沪股通共持有三生国健227.79万股，占流通股2.45%。沪股通减持金额前五个股分别为华钰矿业、洛阳钼业、招商银行、保利发展、中微公司。三生国健近5个交易日上涨1.24%，沪股通累计减持26.88万股；近20个交易日下跌10.31%，沪股通累计减持99.72万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190935159f6868b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190935159f6868b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688336"],"gpt_icon":0},{"id":"2450300887","title":"三生国健(688336.SH)约5.24亿股限售股将于7月22日起上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2450300887","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450300887?lang=zh_cn&edition=full","pubTime":"2024-07-12 18:25","pubTimestamp":1720779950,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生国健(688336.SH)发布公告，本次上市流通的限售股为公司首发限售股，限售股股东数量为7名，股份数量约为5.24亿股，占公司总股本的84.9637%，限售期为自公司股票上市之日(2020年7月22日)起48个月。现限售期即将届满，该部分限售股将于2024年7月22日起上市流通。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1150174.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688336"],"gpt_icon":0},{"id":"2450300537","title":"三生国健：约5.24亿股限售股7月22日解禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2450300537","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450300537?lang=zh_cn&edition=full","pubTime":"2024-07-12 18:16","pubTimestamp":1720779369,"startTime":"0","endTime":"0","summary":"每经AI快讯，三生国健（SH 688336，收盘价：19.78元）7月12日晚间发布公告称，公司限售股份约5.24亿股将于2024年7月22日解禁并上市流通，占公司总股本比例约为84.96%。截至发稿，三生国健市值为122亿元。道达号（daoda1997）“个股趋势”提醒：1. 三生国健近30日内北向资金持股量减少523.17万股，占流通股比例减少5.64%；2. 近30日内无机构对三生国健进行调研。每经头条（nbdtoutiao）——格力：诉小米风扇侵权案胜诉，获赔185万元！小米：未收到任何环境电器相关诉讼，格力再回应(记者 曾健辉)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071218162995acb4fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071218162995acb4fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688336"],"gpt_icon":0},{"id":"2450377537","title":"三生国健07月12日获主力加仓230万元 环比增加318.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450377537","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450377537?lang=zh_cn&edition=full","pubTime":"2024-07-12 15:19","pubTimestamp":1720768781,"startTime":"0","endTime":"0","summary":"07月12日, 三生国健股价涨2.33%，报收19.78元，成交金额4928万元，换手率2.67%，振幅4.19%，量比1.48。三生国健今日主力资金净流入230万元，上一交易日主力净流入55万元，今日环比增加318.18%。该股近5个交易日上涨0.10%，主力资金累计净流入29万元；近20日主力资金累计净流出3177万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071215354095abc743&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071215354095abc743&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688336"],"gpt_icon":0},{"id":"2450548278","title":"三生国健07月10日遭主力抛售174万元 环比增加346.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450548278","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450548278?lang=zh_cn&edition=full","pubTime":"2024-07-10 15:19","pubTimestamp":1720595945,"startTime":"0","endTime":"0","summary":"07月10日, 三生国健股价跌1.10%，报收18.85元，成交金额2215万元，换手率1.26%，振幅4.09%，量比0.67。三生国健今日主力资金净流出174万元，连续5日净流出，上一交易日主力净流出39万元，今日环比增加346.15%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为77.78%，平均跌幅为1.65%。该股近5个交易日下跌2.53%，主力资金累计净流出430万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出3403万元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407101533019f2b34c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407101533019f2b34c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688336","BK0239"],"gpt_icon":0},{"id":"2449249236","title":"三生国健（688336）7月5日主力资金净卖出44.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449249236","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449249236?lang=zh_cn&edition=full","pubTime":"2024-07-06 08:12","pubTimestamp":1720224740,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月5日收盘，三生国健报收于19.76元，上涨5.39%，换手率2.93%，成交量2.72万手，成交额5235.41万元。近5日资金流向一览见下表：三生国健融资融券信息显示，融资方面，当日融资买入180.47万元，融资偿还226.57万元，融资净偿还46.1万元。三生国健主营业务：从事抗体药物的研发、生产及销售业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070600012994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688336"],"gpt_icon":0},{"id":"2449258059","title":"7月5日三生国健涨5.39%，平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449258059","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449258059?lang=zh_cn&edition=full","pubTime":"2024-07-05 16:16","pubTimestamp":1720167361,"startTime":"0","endTime":"0","summary":"证券之星消息，7月5日三生国健涨5.39%，收盘报19.76元，换手率2.93%，成交量2.72万手，成交额5235.41万元。重仓三生国健的公募基金请见下表：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家；过去90天内机构目标均价为31.7。根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为平安医疗健康混合A。该公募基金现任基金经理为周思聪。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705161939957b25f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705161939957b25f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688336","BK0239"],"gpt_icon":0},{"id":"2449253897","title":"三生国健涨5.39%，中泰证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2449253897","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449253897?lang=zh_cn&edition=full","pubTime":"2024-07-05 16:15","pubTimestamp":1720167356,"startTime":"0","endTime":"0","summary":"今日三生国健涨5.39%，收盘报19.76元。2024年4月30日，中泰证券研究员祝嘉琦发布了对三生国健的研报《一季报超预期，基本业务稳健，后续自免管线加速推进》，该研报对三生国健给出“买入”评级。公司作为国内自免领域龙头公司，研发能力雄厚，下一梯队临床管线即将进入商业化。公司一季度业务基本面顺利推进，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中泰证券的祝嘉琦。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500029566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600918","688336"],"gpt_icon":0},{"id":"2448656194","title":"北向资金7月3日净卖出三生国健3.63万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2448656194","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448656194?lang=zh_cn&edition=full","pubTime":"2024-07-04 09:30","pubTimestamp":1720056640,"startTime":"0","endTime":"0","summary":"7月3日，北向资金减持三生国健3.63万股连续3日减持。截止当日收盘，沪股通共持有三生国健277.66万股，占流通股2.99%。沪股通减持金额前五个股分别为长江电力、招商银行、紫金矿业、北汽蓝谷、中国平安。三生国健近5个交易日下跌9.46%，沪股通累计减持22.43万股；近20个交易日下跌14.50%，沪股通累计减持497.64万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407040935169effc439&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407040935169effc439&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688336"],"gpt_icon":0},{"id":"2448187456","title":"三生国健连跌4天，鹏华基金旗下1只基金位列前十大股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2448187456","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448187456?lang=zh_cn&edition=full","pubTime":"2024-07-02 16:44","pubTimestamp":1719909882,"startTime":"0","endTime":"0","summary":"7月2日，三生国健连续4个交易日下跌，区间累计跌幅-7.91%。财报显示，鹏华基金旗下鹏华医药科技股票A进入三生国健前十大股东，且为今年一季度新进。鹏华医药科技股票A基金经理为金笑非。资料显示，鹏华基金管理有限公司成立于1998年12月，董事长为张纳沙，总经理为邓召明。目前，鹏华基金共有3名股东，国信证券股份有限公司持股50%、意大利欧利盛资本资产管理股份公司持股49%、深圳市北融信投资发展有限公司持股1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070216445095654b2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070216445095654b2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688336","BK0239"],"gpt_icon":0},{"id":"2448984928","title":"【读财报】A股7月解禁规模同比下降约18.3% 大全能源、三生国健、百洋医药解禁市值超百亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448984928","media":"新华财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448984928?lang=zh_cn&edition=full","pubTime":"2024-07-01 07:25","pubTimestamp":1719789904,"startTime":"0","endTime":"0","summary":"图1：2023年7月至2024年7月限售股解禁规模具体来看，大全能源、三生国健、百洋医药解禁规模位列前三，解禁市值均超百亿元。本轮限售股解禁市值约为111.94亿元，约占总股本比例约为84.96%。7月解禁市值第三大的公司是百洋医药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407010725369ee8648a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407010725369ee8648a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159982","688303","301015","688336","399300"],"gpt_icon":0},{"id":"2446051855","title":"三生国健（688336）6月27日主力资金净卖出467.86万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446051855","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446051855?lang=zh_cn&edition=full","pubTime":"2024-06-28 08:21","pubTimestamp":1719534080,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年6月27日收盘，三生国健报收于20.48元，下跌4.12%，换手率2.29%，成交量2.12万手，成交额4399.13万元。近5日资金流向一览见下表：三生国健融资融券信息显示，融资方面，当日融资买入146.84万元，融资偿还153.15万元，融资净偿还6.31万元。三生国健主营业务：从事抗体药物的研发、生产及销售业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062800013526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688336"],"gpt_icon":0},{"id":"2446089896","title":"三生国健(688336)：聚焦自免赛道 产品+管线并举构筑自免矩阵","url":"https://stock-news.laohu8.com/highlight/detail?id=2446089896","media":"华福证券有限责...","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446089896?lang=zh_cn&edition=full","pubTime":"2024-06-25 00:00","pubTimestamp":1719244800,"startTime":"0","endTime":"0","summary":"中国银屑病患者人数总体保持稳定，据沙利文估计，2025 年将达至32.5 亿美元并将于2030 年进一步增至99.4 亿美元。608 的II 期临床疗效确切，公司预计2024 递交NDA 上市，位于国产第二梯队。611：国内IL-4R 第一梯队，疗效显著。4 月11 日，金纳单抗的上市申请已获受理，613 公司预计25 年申报NDA，依旧具备强先发优势。老牌抗体公司聚焦自免赛道，上市产品+在研管线并举构筑自免矩阵公司剥离肿瘤资产，将抗肿瘤项目授予沈阳三生，专注于自免赛道。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406251518239f62e0c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406251518239f62e0c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688336","BK0239"],"gpt_icon":0},{"id":"2445768320","title":"“三箭齐发”狙击自身免疫性疾病，三生国健争当中国抗体药物探路者","url":"https://stock-news.laohu8.com/highlight/detail?id=2445768320","media":"浦东发布","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445768320?lang=zh_cn&edition=full","pubTime":"2024-06-21 21:34","pubTimestamp":1718976867,"startTime":"0","endTime":"0","summary":"中国抗体药物探路者20多年前，我国在抗体类药物领域几乎完全依赖进口。“三箭齐发”狙击自免病目前，公司拥有三款已上市的治疗性抗体类药物，分别为：已在国内上市16年的益赛普、2019年上市的健尼哌、2020年上市的赛普汀，已成为公司的三大主力产品。自2019年起，三生国健参与并支持了“强直性脊柱炎健康乡村工程”，帮助广大基层强直患者接受治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062121355295c9a7ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062121355295c9a7ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688336","BK0109","BK0108","BK0239","BK0188","BK0116","BK0085","300005","BK0253"],"gpt_icon":0},{"id":"2444563266","title":"三生国健06月20日主力资金流出30万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2444563266","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444563266?lang=zh_cn&edition=full","pubTime":"2024-06-20 15:18","pubTimestamp":1718867903,"startTime":"0","endTime":"0","summary":"06月20日, 三生国健股价跌0.86%，报收21.82元，成交金额3592万元，换手率1.75%，振幅3.04%，量比0.38。三生国健今日主力资金净流出30万元，连续5日净流出，上一交易日主力净流出241万元，今日环比减少87.55%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为87.50%，平均跌幅为1.38%。该股近5个交易日下跌5.62%，主力资金累计净流出1859万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出2407万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406201528329f518a79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406201528329f518a79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688336","BK0239"],"gpt_icon":0},{"id":"2444142833","title":"三生国健(688336.SH)2023年度拟每股派0.05元 6月26日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2444142833","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444142833?lang=zh_cn&edition=full","pubTime":"2024-06-19 16:39","pubTimestamp":1718786344,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生国健(688336.SH)公告，公司2023年年度拟每股派发现金红利0.05元(含税)，股权登记日2024年6月25日，除权除息日2024年6月26日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1137341.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688336"],"gpt_icon":0},{"id":"2444041305","title":"三生国健刘彦丽去年领薪143.18万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444041305","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444041305?lang=zh_cn&edition=full","pubTime":"2024-06-19 11:14","pubTimestamp":1718766867,"startTime":"0","endTime":"0","summary":"三生国健2023年年报数据显示，公司高管刘彦丽2023年领取的薪酬为143.18万元。三生国健年报数据还显示，2023年度，公司实现营业总收入10.14亿元，同比增长22.84％；实现归属于母公司股东的净利润为2.95亿元，同比增长497.63％。截至2023年底，公司员工总数为965，当年员工人均薪酬为24.66万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061911144095c02e68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061911144095c02e68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688336"],"gpt_icon":0},{"id":"2444817158","title":"三生国健获开源证券买入评级，自免赛道龙头企业，新管线赋能中长期发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2444817158","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444817158?lang=zh_cn&edition=full","pubTime":"2024-06-18 14:30","pubTimestamp":1718692244,"startTime":"0","endTime":"0","summary":"6月18日，三生国健获开源证券买入评级，近一个月三生国健获得1份研报关注。开源证券在研报中预计公司2024-2026年营业收入为12.08/13.40/16.07亿元，同比增长19.14%/10.89%/19.99%。研报认为，公司深耕自免赛道近二十年，目前已有3款单抗产品获批上市，4款核心在研产品进入III期临床。短期看，核心上市产品益赛普销售额企稳回升，赛普汀与健尼哌快速放量，业绩整体稳健增长。中长期维度看，四款自免单品均已进入III期临床，疗效优异进度领先，预计在未来几年将陆续上市，为公司未来业绩增长贡献新动能。风险提示：药物临床研发失败、药物安全性风险、核心成员流失等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406181436139f492fe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406181436139f492fe1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688336","161027"],"gpt_icon":0},{"id":"2444179355","title":"开源证券：给予三生国健买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2444179355","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444179355?lang=zh_cn&edition=full","pubTime":"2024-06-18 14:20","pubTimestamp":1718691623,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,汪晋近期对三生国健进行研究并发布了研究报告《公司首次覆盖报告：自免赛道龙头企业，新管线赋能中长期发展》，本报告对三生国健给出买入评级，当前股价为22.28元。最新盈利预测明细如下：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家；过去90天内机构目标均价为31.57。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061800022647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688336","161027"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-07-22","address":"上海市浦东新区中国(上海)自由贸易试验区李冰路399号","stockEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":-0.105},{"period":"3month","weight":-0.1364},{"period":"6month","weight":-0.0022},{"period":"1year","weight":0.1022},{"period":"ytd","weight":-0.1245}],"companyName":"三生国健药业(上海)股份有限公司","boardCode":"AI0027","perCapita":"53928股","boardName":"医药制造业","registeredCapital":"61678万元","compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0113},{"period":"3month","weight":-0.0191},{"period":"6month","weight":0.0509},{"period":"1year","weight":-0.0642},{"period":"ytd","weight":-0.0036}],"survey":"　　三生国健药业(上海)股份有限公司的主营业务为抗体药物的研发、生产和销售。其主要产品为益赛普、健尼哌、赛普汀。公司共拥有有效专利权合计81项。","serverTime":1721668188597,"listedPrice":28.18,"stockholders":"11437人(较上一季度减少0.08%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三生国健(688336)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三生国健(688336)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三生国健,688336,三生国健股票,三生国健股票老虎,三生国健股票老虎国际,三生国健行情,三生国健股票行情,三生国健股价,三生国健股市,三生国健股票价格,三生国健股票交易,三生国健股票购买,三生国健股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三生国健(688336)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三生国健(688336)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}